IN8BIO, INC. Payments of Stock Issuance Costs
IN8BIO, INC. (INAB) reported Payments of Stock Issuance Costs of $77.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-06
- IN8BIO, INC. payments of stock issuance costs for the quarter ending 2026-06-30 was -$11.00K.
- IN8BIO, INC. payments of stock issuance costs for the quarter ending 2026-03-31 was $88.00K.
- IN8BIO, INC. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00.
- IN8BIO, INC. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- IN8BIO, INC. payments of stock issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- IN8BIO, INC. payments of stock issuance costs for fiscal 2024 was $89.00K.
- IN8BIO, INC. payments of stock issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IN8BIO, INC. payments of stock issuance costs for fiscal 2022 was $919.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 9 month as first filed | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $77.00K 10-Q · filed 2026-08-06 | $77.00K derived: sum of 3 quarters · filed 2026-08-06 | $77.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $88.00K 10-Q · filed 2026-08-06 | $88.00K derived: sum of 2 quarters · filed 2026-08-06 | $88.00K derived: sum of 3 quarters · filed 2026-08-06 | $88.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | -$92.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$92.00K derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$92.00K derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $89.00K 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $92.00K derived: sum of 2 quarters · filed 2025-11-06 | $181.00K 10-Q · filed 2025-11-06 | $89.00K 10-Q · filed 2024-11-12 | $181.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $89.00K 10-Q · filed 2025-08-07 | $89.00K derived: sum of 3 quarters · filed 2025-11-06 | $89.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $89.00K 10-Q · filed 2025-11-06 | $89.00K derived: sum of 2 quarters · filed 2025-11-06 | $89.00K derived: sum of 3 quarters · filed 2025-11-06 | $89.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 | $445.00K 10-K · filed 2024-03-14 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||||
| 2022-12-31 | $919.00K 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |